For the Inventor, By the Inventor

Enter assignee name

Santen Sas

USPTO Granted Patents = 15

% Expired Patents = 20.0

CIPO Patents = 4

EPO Patents = 10

Trademarks = 3

Forward Citations = 16

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Frederic Lallemand (10 out of 14 patents)

Gregory Lambert (8 out of 23 patents)

Betty Philips (8 out of 16 patents)

4. Laura Rabinovich-Guilatt (7 out of 14 patents)

5. Jean-Sébastien Garrigue (4 out of 7 patents)

6. Frédéric Lallemand (3 out of 4 patents)

7. Jean-Sebastien Garrigue (3 out of 3 patents)

8. Philippe Daull (3 out of 3 patents)

9. Christophe Baudouin (2 out of 4 patents)

10. Jeffrey Heier (1 out of 1 patent)

11. Pascal Candillon (1 out of 1 patent)

12. Julien Lafosse (1 out of 1 patent)

13. Betty Phillips (1 out of 1 patent)

14. Laura Rabinovich (1 out of 1 patent)

15. Jennifer Dourlat (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 11612658 - Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same (2023-03-28),

2. 11452739 - Polysaccharides for the treatment of ocular conditions (2022-09-27),

3. 10842873 - Methods for preparing oil-in-water emulsions comprising cetalkonium chloride (2020-11-24),

4. 9956289 - Emulsion compositions containing quaternary ammonium compounds (2018-05-01),

5. 9682147 - Self-preserved oil dispersions comprising boric acid (2017-06-20),

6. 9616016 - Method for treating retinal conditions using an intraocular tamponade (2017-04-11),

7. 9555045 - Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions (2017-01-31),

8. 9364461 - Process for manufacturing ophthalmic oil-in-water emulsions (2016-06-14),

9. 9220694 - Emulsion compositions containing cetalkonium chloride (2015-12-29),

10. 9192567 - Method for treating eye disease or conditions affecting the posterior segment of the eye (2015-11-24),

11. 9132071 - Compositions containing quaternary ammonium compounds (2015-09-15),

12. 9107822 - Water-in oil type emulsion for treating a disease of the eye (2015-08-18),

13. 9089480 - Anionic oil-in-water emulsions containing prostaglandins and uses thereof (2015-07-28),

14. 9072750 - Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions (2015-07-07),

15. 8623852 - Topical methods and compositions for the treatment of eye diseases and conditions (2014-01-07),

Company Overview

Santen Sas, headquartered in Evry, France, is a prominent player in the ophthalmic pharmaceutical industry, focusing on the development and commercialization of innovative therapies for eye diseases. The company specializes in a range of products aimed at addressing various ocular conditions, leveraging advanced research in drug formulation and delivery. With a commitment to improving patient outcomes, Santen Sas operates within a global framework, contributing to the advancement of eye care solutions across diverse markets.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#7 in Evry

#1,259 in France

#39,921 in the World

Santen Sas

Forward Citations = 16

19 inventors:

Frederic Lallemand (10 out of 14 patents)

Gregory Lambert (8 out of 23 patents)

Betty Philips (8 out of 16 patents)

4. Laura Rabinovich-Guilatt (7 out of 14 patents)

5. Jean-Sébastien Garrigue (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Santen Sas. Retrieved from https://idiyas.com/company/santen-sas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…